148 related articles for article (PubMed ID: 15607152)
1. Dosimetric characterization of radioactive sources employed in prostate cancer therapy.
Zilio VO; Joneja OP; Popowski Y; Chawla R
Brachytherapy; 2004; 3(4):201-14. PubMed ID: 15607152
[TBL] [Abstract][Full Text] [Related]
2. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
[TBL] [Abstract][Full Text] [Related]
3. Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source.
Granero D; Pérez-Calatayud J; Ballester F
Radiother Oncol; 2005 Jul; 76(1):79-85. PubMed ID: 16019091
[TBL] [Abstract][Full Text] [Related]
4. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
[TBL] [Abstract][Full Text] [Related]
5. Monte Carlo and experimental characterization of the first AMIRS 103Pd brachytherapy source.
Raisali G; Ghonchehnazi MG; Shokrani P; Sadeghi M
Appl Radiat Isot; 2008 Dec; 66(12):1856-60. PubMed ID: 18657981
[TBL] [Abstract][Full Text] [Related]
6. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
7. Experimental measurements and Monte Carlo calculations of dosimetric parameters of the IRA1-103Pd brachytherapy source.
Sadeghi M; Hosseini SH; Raisali G
Appl Radiat Isot; 2008 Oct; 66(10):1431-7. PubMed ID: 18387806
[TBL] [Abstract][Full Text] [Related]
8. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Nickers P; Thissen B; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric characteristics of the new RadioCoil 103Pd wire line source for use in permanent brachytherapy implants.
Meigooni AS; Zhang H; Clark JR; Rachabatthula V; Koona RA
Med Phys; 2004 Nov; 31(11):3095-105. PubMed ID: 15587663
[TBL] [Abstract][Full Text] [Related]
10. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source.
Sowards KT; Meigooni AS
Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171
[TBL] [Abstract][Full Text] [Related]
11. Determination of dosimetric characteristics of OptiSeed(TM) a plastic brachytherapy (103)Pd source.
Wang Z; Hertel NE
Appl Radiat Isot; 2005 Sep; 63(3):311-21. PubMed ID: 15964196
[TBL] [Abstract][Full Text] [Related]
12. A dosimetric study of Leipzig applicators.
Pérez-Calatayud J; Granero D; Ballester F; Puchades V; Casal E; Soriano A; Crispín V
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):579-84. PubMed ID: 15890603
[TBL] [Abstract][Full Text] [Related]
13. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
Wuu CS; Chen J
Radiat Prot Dosimetry; 2006; 122(1-4):506-8. PubMed ID: 17189276
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma.
Wang Y; Sankreacha R; Al-Hebshi A; Loblaw A; Morton G
Brachytherapy; 2006; 5(4):251-5. PubMed ID: 17118319
[TBL] [Abstract][Full Text] [Related]
15. Monte Carlo dosimetric study of the BEBIG Co-60 HDR source.
Ballester F; Granero D; Pérez-Calatayud J; Casal E; Agramunt S; Cases R
Phys Med Biol; 2005 Nov; 50(21):N309-16. PubMed ID: 16237230
[TBL] [Abstract][Full Text] [Related]
16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
17. Dose distribution for endovascular brachytherapy using Ir-192 sources: comparison of Monte Carlo calculations with radiochromic film measurements.
Sureka CS; Sunny CS; Subbaiah KV; Aruna P; Ganesan S
Phys Med Biol; 2007 Jan; 52(2):525-37. PubMed ID: 17202631
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric parameters of the new design (103)Pd brachytherapy source based on Monte Carlo study.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Phys Med; 2012 Jan; 28(1):13-8. PubMed ID: 21251862
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.
Chibani O; Williamson JF; Todor D
Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786
[TBL] [Abstract][Full Text] [Related]
20. Measurement of dosimetric parameters for the Alpha-Omega high-dose-rate Iridium-192 source.
Muller-Runkel R
Med Dosim; 2005; 30(3):139-42. PubMed ID: 16112463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
